Divis Laboratories Ltd

Further to our intimation dated January 23 2023 we would like to inform that the Board of Directors of the Company at its meeting held on February 03 2023 has inter alia approved the unaudited financial results for the quarter and nine months ended December 31 2022. <BR> <BR> In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the following:<BR> <BR> 1. Unaudited standalone financial results for the quarter and nine months ended December 31 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 2. Unaudited consolidated financial results for quarter and nine months ended December 31 2022 along with Limited Review Report of the Statutory Auditors thereon.<BR> <BR> 3. Press Release on the said financial results of the Company.